ArticleOncotarget2018

Genomic BCR-ABL1 breakpoint characterization by a multi-strategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients.

Cosimo Cumbo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.